CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 27 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 2 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | -75.0% | 2 | -66.7% | 0.00% | – |
Q4 2017 | $8,000 | -42.9% | 6 | -33.3% | 0.00% | – |
Q3 2017 | $14,000 | +7.7% | 9 | +12.5% | 0.00% | – |
Q2 2017 | $13,000 | +44.4% | 8 | +33.3% | 0.00% | – |
Q1 2017 | $9,000 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |